Reversal of clinical features of hurler's disease and biochemical improvement after treatment by bone marrow transplantation

No abstract is available for this paper.

• Publication year

  1982

• Venue

  Journal of Inherited Metabolic Disease

• Publication date

  1982-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/BF01799828
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Enzyme Replacement Therapy by Transplantation of HLA-Compatible Fibroblasts in Sanfilippo A Syndrome

  1981cited by this paper
• Reversal of clinical features of Hurler's disease and biochemical improvement after treatment by bone-marrow transplantation.

  1981cited by this paper
• Enzyme replacement therapy by fibroblast transplantation: long-term biochemical study in three cases of Hunter's syndrome.

  1979cited by this paper
• Enzyme replacement therapy by fibroblast transplantation in a case of Hunter syndrome

  1976cited by this paper
• ALPHA-FETOPROTEIN DURING MID-TRIMESTER INDUCED ABORTION

  1975cited by this paper
• Increased breakdown of glycosaminoglycans and appearance of corrective enzyme after skin transplants in Hunter syndrome

  1975cited by this paper
• Infusion of normal HL-A identical leukocytes in Sanfilippo disease type B. Estimate of infused cell survival by assays of alpha-N-acetylglucosaminidase activity and cytogenetic techniques: effect on glycosaminoglycan excretion in the urine.

  1974cited by this paper
• Mobilization of glycosaminoglycans by plasma infusion in mucopolysaccharidosis type 3--two types of response.

  1973cited by this paper
• Induced degradation of glycosaminoglycans in Hurler's and Hunter's syndromes by plasma infusion.

  1971cited by this paper
• Effect of leukocyte transfusion in a child with type II mucopolysaccharidosis.

  1971cited by this paper
• Hurler and Hunter Syndromes: Mutual Correction of the Defect in Cultured Fibroblasts

  1968cited by this paper

• Carpal tunnel syndrome in mucopolysaccharidosis type I: clinical, surgical and histopathological findings.

  2026cites this paper
• Mucopolysaccharidosis-Plus Syndrome: Is This a Type of Mucopolysaccharidosis or a Separate Kind of Metabolic Disease?

  2024cites this paper
• Bone marrow transplantation increases sulfatase activity in somatic tissues in a multiple sulfatase deficiency mouse model

  2024cites this paper
• Loss of early myeloid donor cell engraftment into the central nervous system with nonmyeloablative conditioning

  2023cites this paper
• Peripheral immune system modulates Purkinje cell degeneration in Niemann–Pick disease type C1

  2023cites this paper
• Advances in therapies for neurological lysosomal storage disorders

  2023cites this paper
• Triamterene Functions as an Effective Nonsense Suppression Agent for MPS I-H (Hurler Syndrome)

  2023cites this paper
• Current and new therapies for mucopolysaccharidoses.

  2022cites this paper
• Treatment of cerebral adrenoleukodystrophy: allogeneic transplantation and lentiviral gene therapy

  2022cites this paper
• Haematopoietic stem cell gene therapy in inborn errors of metabolism

  2022cites this paper
• Current and Future Treatment of Mucopolysaccharidosis (MPS) Type II: Is Brain-Targeted Stem Cell Gene Therapy the Solution for This Devastating Disorder?

  2022influential citation
• Allogeneic hematopoietic stem cell transplantation for inherited metabolic disorders

  2022cites this paper
• Early Neonatal Cardiac Phenotype in Hurler Syndrome: Case Report and Literature Review

  2022cites this paper
• Ameloblastoma in a Three-Year-Old Child with Hurler Syndrome (Mucopolysaccharidosis Type I)

  2022cites this paper
• Mucopolysaccharidosis Type I: Current Treatments, Limitations, and Prospects for Improvement

  2021cites this paper
• The landscape of Mucopolysaccharidosis in Southern and Eastern European countries: a survey from 19 specialistic centers

  2021cites this paper
• Stem cell transplantation for pediatric patients with adrenoleukodystrophy: A nationwide retrospective analysis in Japan

  2021cites this paper
• Long-term evolution of mucopolysaccharidosis type I in twins treated with enzyme replacement therapy plus hematopoietic stem cells transplantation

  2021cites this paper
• Differences in MPS I and MPS II Disease Manifestations

  2021cites this paper
• Milestones in treatments for inborn errors of metabolism: Reflections on Where chemistry and medicine meet

  2021cites this paper
• Gene Therapy for Lysosomal Storage Disorders: Ongoing Studies and Clinical Development

  2021cites this paper
• Mechanisms of demyelination and neurodegeneration in globoid cell leukodystrophy

  2021cites this paper
• GM2 Gangliosidosis: Clinical Features and Current Therapies

  2020cites this paper
• In vitro modelling of neural insult in Mucopolysaccharidosis type 1 hurler using patient-derived human induced pluripotent stem cells

  2020cites this paper
• Bone marrow transplantation in the United Kingdom – past, present and future

  2020cites this paper
• Intravenous Enzyme Replacement Therapy in Mucopolysaccharidoses: Clinical Effectiveness and Limitations

  2020cites this paper
• The Role of Hematopoietic Cell Transplant in the Glycoprotein Diseases

  2020cites this paper
• Therapeutic advances in Fabry disease: The future awaits.

  2020cites this paper
• Clinical trial of laronidase in Hurler syndrome after hematopoietic cell transplantation

  2019cites this paper
• Intrathecal enzyme replacement for Hurler syndrome: biomarker association with neurocognitive outcomes

  2019cites this paper
• Oral manifestation and root canal therapy of the patient with mucopolysaccharidosis

  2019cites this paper
• Improving diagnosis and treatment outcomes in mucopolysaccharidoses

  2019cites this paper
• The hematopoietic stem cell transplantation in children with Hurler syndrome

  2019influential citation
• Therapeutic Options for Mucopolysaccharidoses: Current and Emerging Treatments

  2019cites this paper
• JIMD Reports, Volume 41: Focus Issue: Adults and Metabolism

  2018cites this paper
• The effect of haemopoietic stem cell transplantation on the ocular phenotype in mucopolysaccharidosis type I (Hurler)

  2018cites this paper
• Long-term outcomes of systemic therapies for Hurler syndrome: an international multi-center comparison

  2018cites this paper
• Cell therapy for diverse central nervous system disorders: inherited metabolic diseases and autism

  2018cites this paper
• Total hip arthroplasty in Hurler syndrome - 8 years follow up - A case report with review of literature.

  2018cites this paper
• Effectiveness of Early Hematopoietic Stem Cell Transplantation in Preventing Neurocognitive Decline in Mucopolysaccharidosis Type II: A Case Series.

  2018cites this paper
• Safety of anesthesia for children with mucopolysaccharidoses: A retrospective analysis of 54 patients

  2018cites this paper
• Busulfan, Fludarabine, and Cyclophosphamide (BFC) conditioning allowed stable engraftment after haplo-identical allogeneic stem cell transplantation in children with adrenoleukodystrophy and mucopolysaccharidosis

  2018cites this paper
• Gene therapy for mucopolysaccharidoses: in vivo and ex vivo approaches

  2018cites this paper
• The new frame for Mucopolysaccharidoses

  2018cites this paper
• Characterization of a Mucopolysaccharidosis Type I and GalNAc Transferase deficiency double knockout mouse

  2018cites this paper
• Mortality after hematopoietic stem cell transplantation for severe mucopolysaccharidosis type I: the 30-year University of Minnesota experience

  2017cites this paper
• Cord Blood Transplantations

  2017cites this paper
• Cord blood transplantation in pediatric inherited metabolic diseases: an update on clinical developments

  2017cites this paper
• Stem cell-transplantation therapy for adrenoleukodystrophy: current perspectives

  2017cites this paper
• Objective Quantification of Changes in Corneal Clouding Over Time in Patients With Mucopolysaccharidosis.

  2017cites this paper
• Open issues in Mucopolysaccharidosis type I-Hurler

  2017cites this paper
• Mucopolysaccharidosis IVA and glycosaminoglycans.

  2017cites this paper
• Hematopoietic Stem Cell Gene Therapy for Storage Disease: Current and New Indications.

  2017cites this paper
• Hematopoietic stem cell transplant for the mucopolysaccharidoses

  2016cites this paper
• Hematopoietic stem cell transplantation for Morquio A syndrome.

  2016cites this paper
• Elevated cerebral spinal fluid biomarkers in children with mucopolysaccharidosis I-H

  2016cites this paper
• Haematopoietic stem cell transplantation in inborn errors of metabolism

  2016cites this paper
• Neurodevelopmental Outcome after Hematopoietic Cell Transplantation in Inborn Errors of Metabolism: Current Considerations and Future Perspectives

  2016cites this paper
• Characterization of Hip Morphology in Children With Mucopolysaccharidosis Types I and II

  2016cites this paper
• Gene therapy for leukodystrophy: progress, challenges and opportunities

  2016cites this paper
• The Different Forms of Mucopolysaccharidosis with Neurological Involvement: A Case-Based Review

  2016cites this paper
• Current therapies for Morquio A syndrome and their clinical outcomes

  2016influential citation
• Lysosomal storage disorders: A review of the musculoskeletal features

  2016cites this paper
• Reverse engineering the mechanical and molecular pathways in stem cell morphogenesis

  2015cites this paper
• Enzyme replacement therapy in Hurler syndrome after failure of hematopoietic transplant

  2015cites this paper
• Impact of enzyme replacement therapy and hematopoietic stem cell transplantation in patients with Morquio A syndrome

  2015cites this paper
• Long-term outcome of Hurler syndrome patients after hematopoietic cell transplantation: an international multicenter study.

  2015cites this paper
• Characterization of knee alignment in children with mucopolysaccharidosis types I and II and outcome of treatment with guided growth

  2015cites this paper
• Molecular Therapy and Gene Therapy for Hurler Syndrome A THESIS SUBMITTED TO THE FACULTY OF UNIVERSITY OF MINNESOTA BY Li Ou IN PARTIAL FULFILLMENT OF THE REQUIREMENTS FOR THE DEGREE OF DOCTOR OF PHILOSOPHY

  2015cites this paper
• Bone marrow transplantation improves autoinflammation and inflammatory bone loss in SH3BP2 knock-in cherubism mice.

  2015cites this paper
• Gene therapy for neurologic manifestations of mucopolysaccharidoses

  2015cites this paper
• Long-term functional outcomes of children with hurler syndrome treated with unrelated umbilical cord blood transplantation.

  2015cites this paper
• UvA-DARE ( Digital Academic Repository ) Improving the diagnosis and treatment of MPS

  2015cites this paper
• Diagnosis, classification and treatment of mucopolysaccharidosis type I

  2015cites this paper
• Improving the diagnosis and treatment of MPS I

  2015cites this paper
• MPS I: Early diagnosis, and treatment of bone disease

  2015cites this paper
• Prospective therapies for mucopolysaccharidoses

  2015cites this paper
• impact of enzyme replacement therapy and hematopoietic stem cell transplantation in patients with Morquio A syndrome

  2015cites this paper
• Perioperative complications in patients diagnosed with mucopolysaccharidosis and the impact of enzyme replacement therapy followed by hematopoietic stem cell transplantation at early age

  2014cites this paper
• Heidi Repo Structural studies on lysosomal proteins

  2014cites this paper
• Unrelated CD3/CD19-Depleted Peripheral Stem Cell Transplantation for Hurler Syndrome

  2014cites this paper
• Thoracolumbar Kyphosis in Treated Mucopolysaccharidosis 1 (Hurler Syndrome)

  2014cites this paper
• Enzyme augmentation therapy enhances the therapeutic efficacy of bone marrow transplantation in mucopolysaccharidosis type II mice.

  2014cites this paper
• Stem Cell Transplantation: Genetic Counselors as a Critical Part of the Process

  2014cites this paper
• Transplantation in inborn errors of metabolism: current considerations and future perspectives

  2014cites this paper
• Bone marrow transplant for a boy with alpha-mannosidosis illustrates a family’s decision-making in rare diseases

  2014cites this paper
• Umbilical Cord Blood Transplantation for Inherited Metabolic Diseases

  2014cites this paper
• Unexpected coronary artery findings in mucopolysaccharidosis. Report of four cases and literature review.

  2014cites this paper
• [Hurler syndrome: early diagnosis and treatment].

  2014cites this paper
• Early treatment is associated with improved cognition in Hurler syndrome

  2014cites this paper
• Multi-institutional assessments of transplantation for metabolic disorders.

  2013cites this paper
• Foot and Ankle Abnormalities in the Hurler Syndrome: Additions to the Phenotype

  2013cites this paper
• Mucopolysaccharide Disorders in Orthopaedic Surgery

  2013cites this paper
• UvA-DARE ( Digital Academic Repository ) Mucopolysaccharidosis type I ( MPS I ) : Assessment of disease severity , therapeutic options and early diagnosis

  2013cites this paper
• Current and emerging management options for patients with Morquio A syndrome

  2013cites this paper
• Treatment of mucopolysaccharidosis type III (Sanfilippo syndrome)

  2013influential citation
• Prevalence and development of orthopaedic symptoms in the dutch hurler patient population after haematopoietic stem cell transplantation.

  2013influential citation
• Better BMT for Hurler syndrome--on the level?

  2013cites this paper
• Gauchers Disease—A Reappraisal of Hematopoietic Stem Cell Transplantation

  2013cites this paper
• The effectiveness and cost of enzyme replacement and substrate reduction therapies : a longitudinal cohort study of people with lysosomal storage disorders

  2013cites this paper